TRADING UPDATES: Redcentric buyback progamme; Synectics product launch
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 1.375p on 24-08-2026 at 16:35:06 |
|---|---|
| Change | 0.08p 6.15% |
| Buy | 1.40p |
| Sell | 1.35p |
| Last Trade: | Buy 100,000.00 at 1.38p |
| Day's Volume: | 12,404,636 |
| Last Close: | 1.38p |
| Open: | 1.30p |
| ISIN: | GB00B1VKB244 |
| Day's Range | 1.38p - 1.38p |
| 52wk Range: | 0.22p - 1.425p |
| Market Capitalisation: | £22.16m |
| VWAP: | 1.322509p |
| Shares in Issue: | 1.61b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Genedrive (GDR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 100,000 | 1.38p | Suspected BUY Trade |
16:35:19 - 24-Aug-26 |
| Sell* | 50,000 | 1.3531p | Ordinary |
15:56:21 - 24-Aug-26 |
| Sell* | 30,000 | 1.3689p | Ordinary |
15:55:31 - 24-Aug-26 |
| Sell* | 214,471 | 1.351p | Ordinary |
15:54:17 - 24-Aug-26 |
| Sell* | 200 | 1.35p | SI Trade |
15:54:16 - 24-Aug-26 |
| Sell* | 131 | 1.35p | SI Trade |
15:54:16 - 24-Aug-26 |
| Sell* | 399 | 1.35p | SI Trade |
15:54:16 - 24-Aug-26 |
| Buy* | 418,403 | 1.375p | Ordinary |
15:53:41 - 24-Aug-26 |
| Buy* | 500,000 | 1.367p | Ordinary |
15:49:23 - 24-Aug-26 |
| Buy* | 36,526 | 1.3689p | Ordinary |
15:48:05 - 24-Aug-26 |
Genedrive (GDR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Aug 2026 7:00 am | RNS | Board Appointments |
| 13th Aug 2026 7:00 am | RNS | ShareSoc Investor Presentation |
| 11th Aug 2026 7:00 am | RNS | Completion of PALOH-UK Patient Recruitment |
| 4th Aug 2026 7:00 am | RNS | MT-RNR1 test implemented in the Netherlands |
| 3rd Aug 2026 7:00 am | RNS | New UK clinical guideline for MT-RNR1 testing |
| 14th Jul 2026 7:00 am | RNS | Board Appointment |
| 13th Jul 2026 7:00 am | RNS | Trading Update |
| 10th Jul 2026 7:00 am | RNS-R | UK Minister highlights pharmacogenetic testing |
| 1st Jul 2026 7:00 am | RNS | Board change |
| 29th Jun 2026 7:00 am | RNS | CYP2C19 Agreement with Thermo Fisher Scientific |